Manufacturer:
Glaxo SmithKline
Generic Name:
paroxetine hydrochloride
Status:
On the market
Approved Uses:
antidepressant
major depressive disorder
obsessive compulsive disorder
panic disorder
social anxiety disorder
generalized anxiety disorder
posttraumatic stress
Serious Side Effects:
seizures
newborn heart defects
** Electronic Form Submissions
The mere submission of a contact form does not necessarily form an attorney-client relationship with the Joel Bieber Firm. However, if my case is evaluated and I receive a response from the firm, I understand that an attorney-client relationship will be formed. If I do not receive a response, my case was not evaluated; hence an attorney client relationship has not been formed.
If you send us information electronically via this website, you agree that our review of that information, even if you submitted it in a good faith effort to retain us, and, further, even if it is highly confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you.
I agree that the information that I will receive in response to the above question is general information and I will not be charged for the response to this e-mail question. I further understand that the law for each state may vary, and therefore, I will not rely upon this information as legal advice. Due to the reach of the internet, this matter may require advice regarding my home state; I agree that local counsel may be contacted for referral of this matter.
I understand that additional disclaimer information is viewable under the disclaimer headline (Terms of Use & Privacy Policy) of this website.
|
|
Drug Reactions
The Case Against Paxil
The Joel Bieber Firm is looking at possible problems as a result of the drug Paxil. Here is a story as reported by the Seattle Post-Intelligencer.
"A group of obstetricians cautioned that pregnant women or women planning to become pregnant should avoid the antidepressant Paxil. The opinion, issued by the American College of Obstetricians and Gynecologists, comes nearly a year after the FDA classified the drug as one that poses a risk to the fetus.
Studies have shown that women taking the drug during their first trimester have had babies who suffered heart defects at a rate twice as much as the norm. "
The Associated Press, Seattle Post-Intelligencer 11/30/2006.
Read Article: Seattle Post-Intelligencer
If you believe you have suffered an injury from this prescribed medication,
please fill out the survey below which will start the process.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
|
Refer this Page